Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

CMA alleges Merck Sharp & Dohme broke UK competition law

The Competition and Markets Authority (CMA) has issued a statement of objections alleging that the pharmaceutical company Merck Sharp & Dohme (MSD) broke...Read more

All NSAIDs may increase MI risk, study suggests

According to a meta-analysis recently published in the BMJ (2017;357:j1909), use of NSAIDs is associated with a significant increase in the risk of myocardial...Read more

EMA and the EC publish new EU guidance on biosimilars

The European Medicines Agency (EMA) and the European Commission have jointly published an information guide for healthcare professionals on biosimilar...Read more

New research suggests some statin side-effects have psychosomatic origins

The muscular fatigue and pain commonly included among the side-effects of statins can result from negative perceptions of the drug rather than the drug itself,...Read more

New quality standard for osteoporosis

NICE has published a new quality standard for osteoporosis in adults (QS149), which includes assessing risk and preventing fragility fractures. The standard is...Read more

Featured Articles

Treating scabies infestations in children and adults
Scabies is a skin condition caused by a burrowing mite infestation that usually presents as an itchy papular rash. This article describes how to recognise a scabies infestation and examines the efficacy and suitability of the various treatment options.
Click here to view

Rising to the challenge of male hormonal contraception
Despite decades of research, and surveys showing that the majority of men are willing to try it, a reversible male hormonal contraceptive (MHC) has not yet reached the market. There have been many scientific and regulatory barriers to development but recent advances indicate that MHC is at last a realistic prospect.
Click here to view

Diagnosis and management of nonmelanoma skin cancer
Nonmelanoma skin cancer (NMSC) is the most common form of skin cancer and the prime risk factor is exposure to sunlight. This article describes the main types of NMSC and their clinical presentations, and discusses the management options available.
Click here to view

Web design and marketing agency Leamington Spa